Clonidine Press Articles

Business Wire - BioAlliance Pharma: Full-Year Financial Results for 2011

April 17, 2012 --

Q1 2012 Consolidated Turnover

* a Growth Strategy Focused on Orphan Oncology Products

* Promising Products in Advanced...

continue reading

Business Wire - BioAlliance Pharma Announces: New Achievements in Clonidine Lauriad™ Clinical Development, Second Product of Its Orphan Oncology Portfolio

April 17, 2012 --

PARIS -- Regulatory News:

BioAlliance Pharma SA (Paris:BIO), a Company dedicated to specialty and orphan pharma products in oncology...

continue reading

Business Wire - BioAlliance Pharma announces: Grant of « orphan designation » for clonidine Lauriad™ in Europe

November 2, 2011 -- BioAlliance Pharma announces: Grant of « orphan designation » for clonidine Lauriad™ in Europe

PARIS --...

continue reading

Business Wire - Two key validation steps achieved by BioAlliance Pharma

July 13, 2011 -- HASH(0xff0d4e0)

Validation of Phase III clinical trial application for...

continue reading

Business Wire - APP Pharmaceuticals Announces Approval and Launch of Clonidine Hydrochloride Injection

July 11, 2011 -- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., received approval from the FDA to market...

continue reading

Journal of Family Practice - Q/ Which smoking cessation interventions work best?

July 1, 2011 --

EVIDENCE-BASED ANSWER

A/ NICOTINE REPLACEMENT THERAPY (NRT), bupropion, nortriptyline, clonidine, and varenicline are all effective,...

continue reading

Business Wire - BioAlliance Pharma Submits Application for Orphan Medicinal Product Designation for Clonidine Lauriad™ in Europe and the United States

June 24, 2011 -- BioAlliance Pharma submits application form for orphan medicinal product designation for clonidine Lauriadâ„¢ in Europe and the United...

continue reading

Journal of Family Practice - Strategies for managing hot flashes: hormone therapy—at the lowest possible dose for the shortest period of time—remains the best option for menopausal women with moderate to severe vasomotor symptoms

June 1, 2011 --

PRACTICE RECOMMENDATIONS

* Use hormone therapy (HT) at the lowest effective dose and for the shortest duration possible (preferably...

continue reading

Pediatrics for Parents - Clonidine's Cousin: Kapvay

May 1, 2011 --

A new drug is in town, and even though I don't typically touch upon such new medications in this column until they have more information...

continue reading

Business Wire - BioAlliance Pharma Accelerates Its European Clinical Development of Clonidine Lauriad™

April 27, 2011 -- BioAlliance Pharma accelerates its European clinical development of clonidine Lauriad

The product becomes...

continue reading